- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pre-term Delivery in Canada
Total 723 results
-
University of California, San FranciscoGenentech, Inc.Active, not recruitingPediatric Recurrent/Refractory BRAFV600E-mutant GliomasUnited States, Canada
-
The Hospital for Sick ChildrenCompletedChildhood Solid Tumor | Recurrent Childhood CNS Tumor | Ependymoma, Recurrent ChildhoodUnited States, Canada, Australia
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Ian LawThe Hospital for Sick Children; Mayo Clinic; University of California, Los Angeles and other collaboratorsRecruitingCongenital Heart Disease | Atrial Tachycardia | Atrial Arrhythmia | Pacemaker Re-Entrant TachycardiaUnited States, Canada
-
Intensity Therapeutics, Inc.Bristol-Myers Squibb; Merck Sharp & Dohme LLCCompletedSarcoma | Lymphoma | Breast Cancer | Head and Neck Cancer | Pancreatic Cancer | Lung Cancer | Bile Duct Cancer | Colon Cancer | Liver Cancer | Squamous Cell Carcinoma | Chordoma of SacrumUnited States, Canada
-
Theravance BiopharmaTerminatedSymptomatic Neurogenic Orthostatic HypotensionUnited States, Spain, Portugal, United Kingdom, France, Denmark, Ukraine, Israel, Estonia, Poland, Italy, Russian Federation, Australia, Austria, Bulgaria, Canada, Germany, New Zealand
-
Immunocore LtdCompletedUveal MelanomaSpain, United States, Germany, Canada, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Recurrent Osteosarcoma | Refractory Neuroblastoma | High Risk Neuroblastoma | Resectable OsteosarcomaUnited States, Canada
-
BayerAmgenCompletedMelanomaUnited States, Canada, Germany, France, United Kingdom, Australia, Netherlands
-
Hoffmann-La RocheCompletedMetastatic CancersSpain
-
Bristol-Myers SquibbMedarexCompletedMelanomaFrance, United States, Australia, Belgium, Germany, South Africa, Canada, Brazil, Czech Republic, Hungary
-
Boehringer IngelheimCompletedNeuroectodermal Tumors | RhabdomyosarcomaUnited States, Spain, Canada, Germany, Italy, United Kingdom, Australia, Austria, Denmark, Faroe Islands, France, Netherlands
-
Novartis PharmaceuticalsCompletedGlioma | Astrocytoma | Medulloblastoma | Neuroblastoma | Rhabdomyosarcoma | HepatoblastomaFrance, Canada, Italy, Australia, United Kingdom, United States
-
AstraZenecaCompletedUveal Melanoma | MetastaticUnited States, Czech Republic, Spain, United Kingdom, Germany, Canada, Israel, Netherlands, Belgium, France, Finland
-
Canadian Cancer Trials GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; Trans Tasman...CompletedBrain and Central Nervous System TumorsCanada, Germany, Japan, Netherlands
-
Grupo Español Multidisciplinar de MelanomaBristol-Myers SquibbCompletedMelanoma | Brain MetastasesSpain
-
Novartis PharmaceuticalsCompletedMedulloblastomaFrance, Spain, Germany, Italy, Netherlands, United Kingdom, Canada, Australia, Sweden, United States, Brazil, Switzerland, Russian Federation
-
Philogen S.p.A.RecruitingMelanoma Stage IIIB/CSpain, United States, Switzerland
-
OSI PharmaceuticalsTerminatedRecurrent or Refractory Pediatric EpendymomaUnited States, Canada, United Kingdom
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
Denovo Biopharma LLCCompleted
-
PfizerCompletedGlioblastomaSouth Africa, Italy, Russian Federation, United States, Canada, Germany, Australia, Austria, Croatia, Czech Republic, France, India, Spain
-
Bristol-Myers SquibbCompletedMelanomaGermany, Italy, Sweden, United Kingdom, Belgium, Netherlands, Spain, Finland, Austria, Ireland, Poland, Portugal, Russian Federation, Switzerland, Czechia, Greece, Hungary, Luxembourg, Norway, Romania
-
Hoffmann-La RocheCompletedGlioblastomaUnited Kingdom, Austria, Croatia, France, Italy, Spain, Turkey, Romania, Portugal, Canada, Greece, Sweden, Bulgaria, Estonia, Latvia
-
Hoffmann-La RocheCompletedGlioblastomaUnited States, United Kingdom, France, Italy, Spain, Germany, Canada, Switzerland
-
Day One Biopharmaceuticals, Inc.Pacific Pediatric Neuro-Oncology ConsortiumRecruitingAdvanced Solid Tumor | Low-grade GliomaUnited States, Israel, Korea, Republic of, Denmark, Singapore, Netherlands, Canada, Australia, Germany, Switzerland, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaNetherlands, Korea, Republic of, Spain, Taiwan, Japan, Italy, United States, Singapore, Canada
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Poland, United Kingdom, United States, Spain, Belgium, Denmark, Germany, Norway, Switzerland, Argentina, Austria, Sweden, Czechia, Hungary, Netherlands, Mexico, Canada, Israel, South Africa
-
YM BioSciencesCompletedRecurrent Diffuse Pontine GliomasUnited States, Canada, Israel
-
Grupo Espanol de Tumores NeuroendocrinosCompletedNeuroendocrine Tumors | Neuroendocrine Neoplasm of LungSpain
-
Genta IncorporatedCompletedMelanomaUnited States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
-
BioVex LimitedAmgenCompletedMelanomaUnited States, United Kingdom, Canada, South Africa
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Spain, Germany, Mexico, Turkey, Canada, Austria, Netherlands, United Kingdom, Italy, Georgia, France, Brazil, Romania, Czechia, Argentina, Australia, Ireland, Chile, Hungary, South Africa, Belgium, Poland, Peru
-
Precision Life Sciences GroupMedelis Inc.SuspendedGlioblastoma MultiformeUnited States, Canada, Austria
-
Saint John's Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMelanomaUnited States, Australia, Italy, Spain, Canada, Netherlands, Germany, Finland, Israel, Sweden, Switzerland, United Kingdom
-
Polynoma LLCTerminatedMelanomaUnited States, Canada
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more
-
IpsenTerminatedPancreatic Neuroendocrine TumorSpain, Portugal
-
Synta Pharmaceuticals Corp.TerminatedMelanomaUnited States, Spain, Canada, Australia, Germany, Puerto Rico, Romania, United Kingdom
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Giselle ShollerBeat NB Cancer Foundation; Team Parker for LifeRecruiting
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Iovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Unresectable MelanomaUnited States, Spain, Australia, France, Netherlands, Italy, Canada, Sweden
-
GlaxoSmithKlineCompletedCancerAustralia, Spain, United States, Germany, Poland, Italy, Canada, Ireland, Hungary, Russian Federation, Netherlands, France
-
Global Coalition for Adaptive ResearchBayer; Kazia Therapeutics Limited; Biohaven Pharmaceuticals, Inc.; Kintara Therapeutics... and other collaboratorsRecruitingGlioblastomaUnited States, France, Germany, Canada, Australia, Switzerland
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedGlioblastomaUnited States, Israel, Canada
-
Grupo Español Multidisciplinar de MelanomaRecruitingAdvanced Cancer | Melanoma Stage Iv | Melanoma Stage IiiSpain
-
Bristol-Myers SquibbActive, not recruitingMelanomaUnited States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Mexico, Norway, Romania, Spain, Sweden, Switzerland, United Kingdom